The Clorox Company NYSE: CLX produkty dla domu, do higieny osobistej, chemia domowa
Re: The Clorox Company NYSE: CLX produkty dla domu, do higieny osobistej, chemia domowa
Clorox (NYSE:CLX) stock fell 10% after the consumer goods company disappointed with its full-year sales forecast, as demand for its cleaning products eased from pandemic highs.
Pieniądz robi pieniądz a bieda robi jeszcze wiekszą biedę !!!
REKLAMA
Re: The Clorox Company NYSE: CLX produkty dla domu, do higieny osobistej, chemia domowa
CLX Earnings
Latest Release
Nov 01, 2021
EPS / Forecast
1.21 / 1.03
Revenue / Forecast
1.81B / 1.7B
Latest Release
Nov 01, 2021
EPS / Forecast
1.21 / 1.03
Revenue / Forecast
1.81B / 1.7B
Pieniądz robi pieniądz a bieda robi jeszcze wiekszą biedę !!!
Re: The Clorox Company NYSE: CLX produkty dla domu, do higieny osobistej, chemia domowa
Morgan Stanley upgraded Clorox (NYSE:CLX) to Equalweight from Underweight with a price target of $130.00. Shares were up more than 2% intra-day.
Pieniądz robi pieniądz a bieda robi jeszcze wiekszą biedę !!!
Re: The Clorox Company NYSE: CLX produkty dla domu, do higieny osobistej, chemia domowa
Latest Release
May 02, 2023
EPS / Forecast
1.51 / 1.22
Revenue / Forecast
1.92B / 1.82B
Clorox (NYSE:CLX) reported its Q3 results, with EPS of $1.51 coming in better than the consensus estimate of $1.22. Revenue grew 6% year-over-year to $1.92 billion, beating the consensus estimate of $1.82B, driven largely by a favorable price mix, partially offset by lower volume.
"Our strong results this quarter reflect solid execution against our priorities to rebuild margin and drive top-line growth amid a challenging operating environment. We continue to take a broad set of actions to address persistent cost inflation, including pricing and cost savings efforts,” said CEO Linda Rendle.
The company raised its full 2023-year sales and profit guidance as increased prices of its products are expected to overcome the decrease in demand.
2023 EPS is seen at $4.35-$4.50, better than the consensus of $4.30. Net sales growth is expected in the range of 1%-2%, compared to its prior (4%)-(2%) guidance range.
May 02, 2023
EPS / Forecast
1.51 / 1.22
Revenue / Forecast
1.92B / 1.82B
Clorox (NYSE:CLX) reported its Q3 results, with EPS of $1.51 coming in better than the consensus estimate of $1.22. Revenue grew 6% year-over-year to $1.92 billion, beating the consensus estimate of $1.82B, driven largely by a favorable price mix, partially offset by lower volume.
"Our strong results this quarter reflect solid execution against our priorities to rebuild margin and drive top-line growth amid a challenging operating environment. We continue to take a broad set of actions to address persistent cost inflation, including pricing and cost savings efforts,” said CEO Linda Rendle.
The company raised its full 2023-year sales and profit guidance as increased prices of its products are expected to overcome the decrease in demand.
2023 EPS is seen at $4.35-$4.50, better than the consensus of $4.30. Net sales growth is expected in the range of 1%-2%, compared to its prior (4%)-(2%) guidance range.
Pieniądz robi pieniądz a bieda robi jeszcze wiekszą biedę !!!
Re: The Clorox Company NYSE: CLX produkty dla domu, do higieny osobistej, chemia domowa
This Dividend Growth Stock is Down 30% and is a Buy Right Now
Clorox (CLX) owns a broad collection of iconic brands, but its namesake product is highly correlated with cleaning. The stock took off in 2020 as the coronavirus spread across the globe and disinfecting surfaces to stop the spread became a priority. Eventually, though, pandemic concerns eased.
Today Clorox stock is trading down roughly 30% from the high-water mark achieved in 2020. Here’s what went wrong and why investors should still like the shares.
Ups and downs for Clorox
Demand for cleaning products spiked in the early days of the pandemic as people started to clean just about everything in an attempt to avoid the illness. There was so much buying that Clorox couldn’t keep up, so it hired contract manufacturers to produce its products for it. That kept retailers’ shelves filled, but it came at a high cost. Investors only looked at the demand side of the equation in a time of market turmoil and sent Clorox’s shares sharply higher.
Then inflation started to rise, and demand for cleaning supplies started to drop. The end result was massive margin compression. For example, gross profit margin had long hovered in the mid-40% range but fell down to the mid-30% range. Investors, perhaps understandably, dumped the stock.
Management was confident that it could get margins back on track. The game plan was pretty simple and followed the plan used by just about every consumer staples company: Cut costs and raise prices. There were some easy fixes, like getting rid of high-cost contract production, but management admitted that getting back to the historical margin range was likely to be a multiyear effort.
Clorox’s efforts are going quite well, thanks
The company is now many quarters into the process, and it appears to be executing at a high level. For example, in the fiscal third quarter of 2023 (ended March 31), organic sales rose a solid 8%, led by price increases. Gross margin improved 590 basis points year over year to 41.8%. And adjusted earnings, which leaves out items the company believes are one-time in nature, rose 15% compared to the same stanza of fiscal 2022. All in, it was a solid quarter.
That said, there are some caveats. For example, price increases were quite large in some business lines leading to very material volume declines. Management said that the volume declines were in line with expectations, but other consumer products companies are doing a better job at balancing price increases and volume declines. At some point, Clorox will need to address the volume issue when the price increases run their course.
However, given the company’s long-term success and the fact that it is executing on its current plan to improve margins, it seems like a good idea to give it the benefit of the doubt here. It’s worth noting that Clorox has increased its dividend annually for over four and half decades. That’s a record that requires both commitment and execution to achieve.
Over the past decade, meanwhile, the average annual dividend increase was 6.5%. In today’s high-inflation environment, that may not sound like much, but this is a boring consumer staples stock, and that figure is pretty solid. That said, the average has been brought down by slower dividend growth during the recent lean years, as you would expect. To put a number on that, the last increase, made in mid-2022, amounted to just 1.7%. The increase in 2019, before the pandemic upended the world, was 10.4%.
While it may take some time, Clorox is clearly making progress in getting back toward 2019 performance levels. And that would likely mean a return to more robust dividend growth rates. The stock’s 2.8% dividend yield, meanwhile, is still toward the high side of the historical yield range, suggesting the shares remain relatively cheap.
Not an overnight success
To be fair, Clorox still has a lot of work ahead of it as it attempts to return to pre-COVID levels of business performance. But it has, so far, executed fairly well on its recovery plan. That’s a very good sign for the future. In fact, during the earnings conference call, two analysts pressed the company on its earnings potential. Analyst earnings models suggest huge earnings upside in the future, and they wanted to make sure they weren’t missing something. Management didn’t really try to temper the analysts’ positive outlooks.
— Reuben Gregg Brewer
https://dailytradealert.com/2023/05/12/ ... right-now/
Clorox (CLX) owns a broad collection of iconic brands, but its namesake product is highly correlated with cleaning. The stock took off in 2020 as the coronavirus spread across the globe and disinfecting surfaces to stop the spread became a priority. Eventually, though, pandemic concerns eased.
Today Clorox stock is trading down roughly 30% from the high-water mark achieved in 2020. Here’s what went wrong and why investors should still like the shares.
Ups and downs for Clorox
Demand for cleaning products spiked in the early days of the pandemic as people started to clean just about everything in an attempt to avoid the illness. There was so much buying that Clorox couldn’t keep up, so it hired contract manufacturers to produce its products for it. That kept retailers’ shelves filled, but it came at a high cost. Investors only looked at the demand side of the equation in a time of market turmoil and sent Clorox’s shares sharply higher.
Then inflation started to rise, and demand for cleaning supplies started to drop. The end result was massive margin compression. For example, gross profit margin had long hovered in the mid-40% range but fell down to the mid-30% range. Investors, perhaps understandably, dumped the stock.
Management was confident that it could get margins back on track. The game plan was pretty simple and followed the plan used by just about every consumer staples company: Cut costs and raise prices. There were some easy fixes, like getting rid of high-cost contract production, but management admitted that getting back to the historical margin range was likely to be a multiyear effort.
Clorox’s efforts are going quite well, thanks
The company is now many quarters into the process, and it appears to be executing at a high level. For example, in the fiscal third quarter of 2023 (ended March 31), organic sales rose a solid 8%, led by price increases. Gross margin improved 590 basis points year over year to 41.8%. And adjusted earnings, which leaves out items the company believes are one-time in nature, rose 15% compared to the same stanza of fiscal 2022. All in, it was a solid quarter.
That said, there are some caveats. For example, price increases were quite large in some business lines leading to very material volume declines. Management said that the volume declines were in line with expectations, but other consumer products companies are doing a better job at balancing price increases and volume declines. At some point, Clorox will need to address the volume issue when the price increases run their course.
However, given the company’s long-term success and the fact that it is executing on its current plan to improve margins, it seems like a good idea to give it the benefit of the doubt here. It’s worth noting that Clorox has increased its dividend annually for over four and half decades. That’s a record that requires both commitment and execution to achieve.
Over the past decade, meanwhile, the average annual dividend increase was 6.5%. In today’s high-inflation environment, that may not sound like much, but this is a boring consumer staples stock, and that figure is pretty solid. That said, the average has been brought down by slower dividend growth during the recent lean years, as you would expect. To put a number on that, the last increase, made in mid-2022, amounted to just 1.7%. The increase in 2019, before the pandemic upended the world, was 10.4%.
While it may take some time, Clorox is clearly making progress in getting back toward 2019 performance levels. And that would likely mean a return to more robust dividend growth rates. The stock’s 2.8% dividend yield, meanwhile, is still toward the high side of the historical yield range, suggesting the shares remain relatively cheap.
Not an overnight success
To be fair, Clorox still has a lot of work ahead of it as it attempts to return to pre-COVID levels of business performance. But it has, so far, executed fairly well on its recovery plan. That’s a very good sign for the future. In fact, during the earnings conference call, two analysts pressed the company on its earnings potential. Analyst earnings models suggest huge earnings upside in the future, and they wanted to make sure they weren’t missing something. Management didn’t really try to temper the analysts’ positive outlooks.
— Reuben Gregg Brewer
https://dailytradealert.com/2023/05/12/ ... right-now/
Pieniądz robi pieniądz a bieda robi jeszcze wiekszą biedę !!!
Re: The Clorox Company NYSE: CLX produkty dla domu, do higieny osobistej, chemia domowa
Dividend Aristocrat #Clorox hikes dividend by 1.7 percent. $CLX
Pieniądz robi pieniądz a bieda robi jeszcze wiekszą biedę !!!
Re: The Clorox Company NYSE: CLX produkty dla domu, do higieny osobistej, chemia domowa
02.08.23
Clorox (NYSE:CLX) 8% HIGHER; reported Q4 EPS of $1.67, $0.51 better than the analyst estimate of $1.16. Revenue for the quarter came in at $2B versus the consensus estimate of $1.88B. Clorox sees FY2024 EPS of $5.60-$5.90, versus the consensus of $5.63. Net sales are expected to be flat to up 2% compared to the prior year. Organic sales are expected to be up 2% to up 4%
Clorox (NYSE:CLX) shares jumped more than 6% after-hours following the company’s reported Q4 results, with EPS of $1.67 coming in better than the consensus estimate of $1.16.
Revenue grew 12% year-over-year to $2 billion, beating the consensus estimate of $1.88B, driven largely by favorable price mix, partially offset by lower volume and unfavorable foreign exchange rates. Organic sales grew 14% year-over-year.
"Over the course of the year, we've been relentlessly focused on driving top-line growth while rebuilding margins in the midst of a challenging operating environment as we continue to advance our long-term strategy to invest in our advantaged portfolio of superior brands, advance our digital transformation, and streamline our operating model,” said CEO Linda Rendle.
For the full 2024 year, the company expects EPS in the range of $5.60-$5.90, compared to the consensus estimate of $5.63. Revenue is expected to grow 0-2% year-over-year. Organic sales are expected to grow in the range of 2-4%.
Clorox (NYSE:CLX) 8% HIGHER; reported Q4 EPS of $1.67, $0.51 better than the analyst estimate of $1.16. Revenue for the quarter came in at $2B versus the consensus estimate of $1.88B. Clorox sees FY2024 EPS of $5.60-$5.90, versus the consensus of $5.63. Net sales are expected to be flat to up 2% compared to the prior year. Organic sales are expected to be up 2% to up 4%
Clorox (NYSE:CLX) shares jumped more than 6% after-hours following the company’s reported Q4 results, with EPS of $1.67 coming in better than the consensus estimate of $1.16.
Revenue grew 12% year-over-year to $2 billion, beating the consensus estimate of $1.88B, driven largely by favorable price mix, partially offset by lower volume and unfavorable foreign exchange rates. Organic sales grew 14% year-over-year.
"Over the course of the year, we've been relentlessly focused on driving top-line growth while rebuilding margins in the midst of a challenging operating environment as we continue to advance our long-term strategy to invest in our advantaged portfolio of superior brands, advance our digital transformation, and streamline our operating model,” said CEO Linda Rendle.
For the full 2024 year, the company expects EPS in the range of $5.60-$5.90, compared to the consensus estimate of $5.63. Revenue is expected to grow 0-2% year-over-year. Organic sales are expected to grow in the range of 2-4%.
Pieniądz robi pieniądz a bieda robi jeszcze wiekszą biedę !!!
Re: The Clorox Company NYSE: CLX produkty dla domu, do higieny osobistej, chemia domowa
Clorox Co (NYSE:CLX) fell 2% after the company said the cybersecurity attack last month -- which damaged portions of its IT infrastructure and caused widespread disruption of operations -- was expected to have a material impact on its fiscal first quarter results.
Pieniądz robi pieniądz a bieda robi jeszcze wiekszą biedę !!!
Re: The Clorox Company NYSE: CLX produkty dla domu, do higieny osobistej, chemia domowa
DA Davidson upgraded shares of Clorox (NYSE:CLX) to Buy from Neutral with a $152 per share price target in a note Monday.
Analysts told investors that the stock appears to be discounting the worst, but in their view, prior to a recent cyberattack, the company's fundamentals were solid.
"CLX is -18% since disclosing on August 14th a crippling cyberattack. On Friday, they said all manufacturing sites are now operating. We believe that when CLX quantifies the financial impacts, uncertainty will be reduced and shares could rally," they explained.
"We are cutting our estimates to low enough levels (we believe), with a 15% cut to FY24E EPS and, assuming some longer-term share impacts, a 10% cut to FY25E EPS. We are tweaking our target P/E to 27x from 25x (sentiment should improve from here), around the mid-point of the 5-year range of 20x-32x," the analysts added.
Focusing on the stock's fundamentals, Weiser said the 25% rally in the first four months of 2023 was driven by several consecutive quarters with upside sales and earnings surprises, while gross margin had been recovering strongly due to price increases that were accompanied by better-than-historical volume demand elasticities.
Pieniądz robi pieniądz a bieda robi jeszcze wiekszą biedę !!!
Re: The Clorox Company NYSE: CLX produkty dla domu, do higieny osobistej, chemia domowa
(Reuters) - Akcje Clorox (NYSE:CLX) spadły w czwartek o 8,1%, po osiągnięciu najniższego poziomu od maja 2018 r., po tym, jak firma produkująca środki czystości ostrzegła, że sierpniowy cyberatak spowoduje kwartalną stratę i zmniejszy przychody nawet o 28%.
Akcje Clorox ostatnio notowane były na poziomie 121,16 USD po wcześniejszym osiągnięciu niskiego poziomu 119,56 USD i odnotowały największą jednodniową stratę procentową od lutego 2022 r.
W środę późnym wieczorem Clorox prognozował stratę na akcję w wysokości od 0,35 USD do 0,75 USD za pierwszy kwartał fiskalny zakończony 30 września, w porównaniu z zyskiem sprzed roku w wysokości 0,68 USD. Powiedział, że sprzedaż netto spadnie rok do roku o 23% do 28%.
Następnie Evercore ISI obniżył cenę docelową Clorox do 120 USD ze 160 USD, a Raymond James obniżył ją do "wyników rynkowych" z "przewyższających". Bank of America obniżył cenę docelową do 120 USD ze 145 USD, podczas gdy Deutsche Bank obniżył swój cel do 136 USD ze 155 USD.
Analityk BoFA Anna Lizzul, która ocenia Clorox jako "gorzej", powiedziała, że ostrzeżenie o spadku marży brutto w pierwszym kwartale jest "szczególnie godne uwagi", ponieważ spodziewała się, że będzie to "największy kwartał pod względem wzrostu marży brutto" w roku podatkowym 2024.
Wraz z atakiem i trudnym środowiskiem konsumenckim, Lizzul powiedział, że rosnące koszty wysyłki z wyższych cen ropy mogą również zmusić Clorox do zmniejszenia aktywności promotalsolu w roku podatkowym 2024 w celu ochrony marż.
A Lizzul widział "niewielki potencjał do podniesienia cen", ponieważ w ciągu ostatnich 2 lat dokonał czterech rund podwyżek.
14 sierpnia Clorox powiedział, że wyłączył niektóre systemy po tym, jak nieautoryzowana aktywność zakłóciła operacje. Następnie 18 września stwierdzono, że wyniki pierwszego kwartału mogą mieć "istotny wpływ".
29 września poinformował, że wszystkie jego zakłady produkcyjne wznowiły działalność i że zwiększa produkcję, aby uzupełnić zapasy po ataku.
Jednak analityk Evercore ISI, Javier Escalante, który ocenia Clorox jako "słabe", wyraził obawy dotyczące tego, ile czasu zajęło firmie opracowanie wpływu finansowego. Wskazał również na ostrzeżenie o "bieżącym, ale zmniejszającym się wpływie operacyjnym w drugim kwartale".
Escalante opisał to jako "niepokojący" rozdźwięk między operacjami, planowaniem finansowym i raportowaniem w swojej notatce badawczej.
Akcje Clorox ostatnio notowane były na poziomie 121,16 USD po wcześniejszym osiągnięciu niskiego poziomu 119,56 USD i odnotowały największą jednodniową stratę procentową od lutego 2022 r.
W środę późnym wieczorem Clorox prognozował stratę na akcję w wysokości od 0,35 USD do 0,75 USD za pierwszy kwartał fiskalny zakończony 30 września, w porównaniu z zyskiem sprzed roku w wysokości 0,68 USD. Powiedział, że sprzedaż netto spadnie rok do roku o 23% do 28%.
Następnie Evercore ISI obniżył cenę docelową Clorox do 120 USD ze 160 USD, a Raymond James obniżył ją do "wyników rynkowych" z "przewyższających". Bank of America obniżył cenę docelową do 120 USD ze 145 USD, podczas gdy Deutsche Bank obniżył swój cel do 136 USD ze 155 USD.
Analityk BoFA Anna Lizzul, która ocenia Clorox jako "gorzej", powiedziała, że ostrzeżenie o spadku marży brutto w pierwszym kwartale jest "szczególnie godne uwagi", ponieważ spodziewała się, że będzie to "największy kwartał pod względem wzrostu marży brutto" w roku podatkowym 2024.
Wraz z atakiem i trudnym środowiskiem konsumenckim, Lizzul powiedział, że rosnące koszty wysyłki z wyższych cen ropy mogą również zmusić Clorox do zmniejszenia aktywności promotalsolu w roku podatkowym 2024 w celu ochrony marż.
A Lizzul widział "niewielki potencjał do podniesienia cen", ponieważ w ciągu ostatnich 2 lat dokonał czterech rund podwyżek.
14 sierpnia Clorox powiedział, że wyłączył niektóre systemy po tym, jak nieautoryzowana aktywność zakłóciła operacje. Następnie 18 września stwierdzono, że wyniki pierwszego kwartału mogą mieć "istotny wpływ".
29 września poinformował, że wszystkie jego zakłady produkcyjne wznowiły działalność i że zwiększa produkcję, aby uzupełnić zapasy po ataku.
Jednak analityk Evercore ISI, Javier Escalante, który ocenia Clorox jako "słabe", wyraził obawy dotyczące tego, ile czasu zajęło firmie opracowanie wpływu finansowego. Wskazał również na ostrzeżenie o "bieżącym, ale zmniejszającym się wpływie operacyjnym w drugim kwartale".
Escalante opisał to jako "niepokojący" rozdźwięk między operacjami, planowaniem finansowym i raportowaniem w swojej notatce badawczej.
Pieniądz robi pieniądz a bieda robi jeszcze wiekszą biedę !!!
REKLAMA
Kto jest online
Użytkownicy przeglądający to forum: Obecnie na forum nie ma żadnego zarejestrowanego użytkownika i 7 gości